Lp(a) and CV Risk; CRP Levels and High-Risk Vulnerable Plaque post-NSTEMI; Pulsed Field Ablation vs. Cryoablation for Paroxysmal AFib
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Dyslipidemia, Noninvasive Imaging, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Lipid Metabolism, Nonstatins, Echocardiography/Ultrasound
Keywords: Cholesterol, LDL, Atherosclerosis, Risk Assessment, Risk Factors, C-Reactive Protein, Ultrasonography, Interventional, Plaque, Atherosclerotic, Spectroscopy, Near-Infrared, Cryosurgery, Tachycardia, Ectopic Atrial, Atrial Fibrillation
